BMJ Evidence-Based Medicine

Article	Citations
Development of a generalised tool for evaluating success of clinical practice guidelines implementation (A-GIST)	303
High-value care education can learn from the evidence-based medicine movement: moving beyond competencies and curricula to culture	212
Proposed framework for unifying disease definitions in guideline development	88
How to best convey continuous outcomes in patient decision aids	76
Challenges to delivering evidence-based management for long COVID	76
Decision architecture randomisation: extremely efficient clinical trials that preserve clinician and patient choice?	65
Associations between device-measured and self-reported physical activity and common mental disorders: Findings from a large-scale prospective cohort study	61
Evolution of evidence on overall survival benefits of cancer drugs included on the national reimbursement drug list of China, 2005–2022: an observational study	61
Examining the layered health literacy demands in low-value care contexts	61
Global considerations for informed consent with shared decision-making in the digital age	49
Rapid reviews methods series: assessing the appropriateness of conducting a rapid review	44
Educating health professionals in evidence-based practice in 2026	43
Gender and geographical bias in the editorial decision-making process of biomedical journals: a case-control study	40
Making sustainable healthcare decisions: three turns towards sustainable guidelines	40
Measuring progress in institutionalising evidence-informed priority-setting in the Indian healthcare system: an application using the iProSE scale	38
Over 1000 terms have been used to describe evidence synthesis: a scoping review	38
Reconsidering the role of tramadol in chronic pain management	35
Ataluren for Duchenne: how politics and social pressure undermined evidence-based decisions	34
Deceptive shifts in cancer stage distribution	31
Exploring the diverse definitions of ‘evidence’: a scoping review	30
Patient-reported outcomes and acupuncture-related adverse events are overlooked in acupuncture randomised controlled trials: a cross-sectional meta-epidemiological study	28
Acupuncture for acute migraine attacks in adults: a systematic review and meta-analysis	28
Assessing proposals to update established screening strategies	27
Leading with options or issues to support purposeful shared decision-making in clinical practice	27
An opportunity for evidence-based care of individuals with monkeypox	27

Top 15 Choosing Wisely international campaign recommendations to reduce low-value care	26
Evidence categories in systematic assessment of cancer overdiagnosis	26
Romanticised semiology	26
Dynamic intervention strategies await inclusion in clinical evidence synthesis	25
How to use the regulatory data from Health Canada for secondary analyses on new drugs, biologics and vaccines	24
iHealthFacts: a health fact-checking website for the public	23
Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India	22
FDA approval of benzgalantamine exposes flaws in the 505(b)(2) pathway for innovations on existing drugs	22
Ambiguity in care delivery terminology: implications that affect pragmatic clinical trials using non-pharmacological interventions	21
Challenges in the selection and measurement of outcomes in psychiatric trials	21
Catalogue of bias: novelty bias	20
Genetic predisposition, modifiable lifestyles, and their joint effects on human lifespan: evidence from multiple cohort studies	19
Count outcomes, rate ratios and rate differences	19
Using a journal club to navigate a maze of COVID-19 papers in a front-line hospital service	18
Development of the Reporting Infographics and Visual Abstracts of Comparative studies (RIVA-C) checklist and guide	18
Is a one-size-fits-all ‘12-month rule’ appropriate when it comes to the last search date in systematic reviews?	18
Overcoming challenges in the implementation of clinical practice guidelines in China	17
Survey of US physicians’ attitudes and knowledge of AI	17
Direct-to-consumer advertising: a modifiable driver of overdiagnosis and overtreatment	17
Rapid reviews methods series: Guidance on assessing the certainty of evidence	16
Piloting a new method to estimate action thresholds in medicine through intuitive weighing	16
Are we ready for AI-augmented generalists?	16
De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a systematic review and network meta-analysis	16
Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method	16
Alcohol use and risk of dementia in diverse populations: evidence from cohort, case–control and Mendelian randomisation approaches	15
Effects of various exercise interventions in insomnia patients: a systematic review and network meta-analysis	15
Outcomes of the first national oral cancer screening programme in Taiwan, 2004–2022: a population-based study	14
Effectiveness and clinical relevance of kinesio taping in musculoskeletal disorders: an overview of systematic reviews and evidence mapping	14
Improving peer review of systematic reviews and related review types by involving librarians and information specialists as methodological peer reviewers: a randomised controlled trial	13
Enhancing the transparency of clinical practice guidelines by prospective registration: the PREPARE platform	13
Time deficiency: an affliction of healthcare systems and how to ameliorate it	13
Correspondence on “How methodological pitfalls have created widespread misunderstanding about long COVID” by Høeget al	13
Perspectives of clinicians and screening candidates on shared decision-making in prostate cancer screening with the prostate-specific antigen (PSA) test: a qualitative study (PROSHADE study)	13
Likelihood ratio interpretation of the relative risk	13
Trump’s statements about acetaminophen and the problem of epistemic corrections	12
Less is more for patients, practitioners, public and planet: a taxonomy for the harms of too much medicine	11
Consistency between trials presented at conferences, their subsequent publications and press releases	11
Reducing the residue of retractions in evidence synthesis: ways to minimise inappropriate citation and use of retracted data	11
Advancing the ‘Choosing Wisely’ campaign to reduce low-value care in China	11
Clinical effect and contributing factors of acupuncture for knee osteoarthritis: a systematic review and pairwise and exploratory network meta-analysis	11
Understanding synthetic data: artificial datasets for real-world evidence	10
Rapid reviews methods series: practical guidance for conducting timely evidence syntheses	10
Adherence to the Guideline for Reporting Evidence-based practice Educational interventions and Teaching (GREET) of studies on evidence-based healthcare e-learning: a cross-sectional study	10
How to interpret studies using Mendelian randomisation	10
Mind the gaps between patient experiences and their expectations about outcomes	10
Rapid Reviews Methods Series: Involving patient and public partners, healthcare providers and policymakers as knowledge users	10
Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting	9
A primer to planetary health in evidence-based medicine and clinical decision-making	9
Problem-based shared decision-making in diabetes care: a secondary analysis of video-recorded encounters	9
How to promote the application of reporting guidelines in acupuncture research	9

Responsible dissemination of health and medical research: some guidance points	9
Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study	9
Retrieval barriers in individual participant data reviews with network meta-analysis	9
Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation	9
Perspectives on the definition of ‘evidence’: a qualitative interview study among interest-holders	9
Role of overdiagnosis in the rising incidence of endometrial cancer: a population-based ecological study	9
Clinician and health service interventions to reduce the greenhouse gas emissions generated by healthcare: a systematic review	8
Comparing traditional and AI-enhanced strategies for developing patient decision aids: a multiple case study	8
Cluster-randomised controlled trials	8
Perspectives from China, India and Sri Lanka on the drivers and potential solutions to overuse and overdiagnosis	8
Overly complex methods may impair pragmatic use of core evidence-based medicine principles	8
Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial	8
Reporting guideline for the use of Generative Artificial intelligence tools in MEdical Research: the GAMER Statement	8
Preventing overdiagnosis and overuse: proposed guidance for guideline panels	8
Revisiting the value of Archie Cochrane’s contributions	8
Using individual participant data to improve network meta-analysis projects	8
AI in healthcare: an introduction for clinicians	8
Clinical trial design and treatment effects: a meta-analysis of randomised controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications	8
Integrating large language models in systematic reviews: a framework and case study using ROBINS-I for risk of bias assessment	7
Tramadol versus placebo for chronic pain: a systematic review with meta-analysis and trial sequential analysis	7
Enhancing title and abstract screening for systematic reviews with GPT-3.5 turbo	7
Identifying and counteracting fraudulent responses in online recruitment for health research: a scoping review	7
Reducing the environmental impact of healthcare to improve health, sustainability and equity	7
CARE extension guideline for acupuncture case reports	7
Twenty-one years of the International Shared Decision Making Conference: lessons learnt and future priorities	6
Effectiveness and tolerability of pharmacological prophylaxis for migraine headaches: a systematic review and network meta-analysis of randomised controlled trials	6
Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemic	6
Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health	6
Integrating a climate lens into the design of education programmes for health professionals	6
Incomplete reporting and spin in acupuncture randomised controlled trials: a cross-sectional meta-epidemiological study	6
The path of Chile towards the institutionalisation of evidence-based health policy	6
Rapid reviews methods series: Guidance on literature search	6
Correspondence on ‘Less is more for patients, practitioners, public and planet: a taxonomy for the harms of too much medicine’	6
Hidden risks of predictive models in healthcare	6
Toward automating GRADE classification: a proof-of-concept evaluation of an artificial intelligence-based tool for semiautomated evidence quality rating in systematic reviews	6
Feasibility of multiorgan risk prediction with routinely collected diagnostics: a prospective cohort study in the UK Biobank	6
Different meta-analysis methods can change judgements about imprecision of effect estimates: a meta-epidemiological study	5
Improving inclusivity in UK clinical trials through good practice in the collection and use of ethnicity data: recommendations from the INCLUDED study	5
Accurate is not enough: select formats for communicating probabilities to achieve specific outcomes	5
Assessing shared decision-making in clinical practice: a systematic review and meta-analysis of studies using OPTION-12 and OPTION-5	5
Ten resources for understanding bias in health research: EBM live workshop 2022	5
Interpreting the results from the first randomised controlled trial of colonoscopy: does it save lives?	5
Insights on the German College of General Practitioners and Family Physicians (DEGAM) guideline addressing medical overuse	5
Co-production and implementation of an evidence collation strategy for a novel point-of-care information resource: gpevidence.org	5
Applying the time needed to treat to NICE guidelines on lifestyle interventions	5
Does the format of result presentation and type of conclusion in Cochrane plain language summaries matter? A randomised controlled trial	5
Correspondence on ‘The limits of shared decision making’ by Elwynet al: We call for a more nuanced approach	5
Metro Mapping: development of an innovative methodology to co-design care paths to support shared decision making in oncology	5
Identifying actionable statements in Chinese health guidelines: a cross-sectional study	5
Teaching evidence-based medicine by using a systematic review framework: implementation in a Swedish university setting	5
Smartphone apps for point-of-care information summaries: systematic assessment of the quality and content	5
Advancing evidence-based medicine in China: an interview with Gordon Guyatt	5
Context matters! What is really tested in an RCT?	5
Meta-analysis of continuous outcomes: a user’s guide for analysis and interpretation	5
In-person schooling is essential even during periods of high transmission of COVID-19	5
Attitudes of people living with cancer towards trial non-publication and research participation	5
Rapid review method series: interim guidance for the reporting of rapid reviews	4
Efforts towards the institutionalisation of evidence-informed decision-making	4
All health is not equal: the use of modifiers in NICE technology appraisal	4
Use of digital patient decision-support tools for atrial fibrillation treatments: a systematic review and meta-analysis	4
Implementing AI models in clinical workflows: a roadmap	4
Enhanced access but increased testing with virtual care: insights from a multinational survey	4
When does the placebo effect have an impact on network meta-analysis results?	4
Health technology assessment in India in the next decade: reflections on a vision for its path to maturity and impact	4
Evaluation of reported claims of sex-based differences in treatment effects across meta-analyses: a meta-research study	4
Shared decision-making as a method of care	4
Bias, quality and reporting in health research: differences and tools for appraisal	4
From promise to practice: challenges and pitfalls in the evaluation of large language models for data extraction in evidence synthesis	4
Towards transparency: adoption of WHO best practices in clinical trial registration and reporting among top medical research funders in the USA	4
Reducing low value care: opportunities and challenges for Choosing Wisely campaigns	4
Caring without boundaries: delimiting shared decision-making	3
Rapid reviews methods series: guidance on rapid scoping, mapping and evidence and gap map (‘Big Picture Reviews’)	3
What makes a ‘good’ decision with artificial intelligence? A grounded theory study in paediatric care	3
Patient-reported effects of hospital-wide implementation of shared decision-making at a university medical centre in Germany: a pre–post trial	3
Standardised mean difference	3
Reporting health and medical research	3
Diagnostic accuracy of dipsticks for urinary tract infections in acutely hospitalised patients: a prospective population-based observational cohort study	3
Reliance on the highest-quality studies of Long Covid is appropriate and not evidence of bias	3
Adverse effects of overdiagnosis on our understanding of disease	3
Using and distinguishing evidence from non-randomised studies of interventions	3

Developing a core outcome set for dysphagia interventions in Parkinson’s disease: an international Delphi consensus study	3
AI-driven speech biomarkers for disease diagnosis and monitoring: a systematic review and meta-analysis	3
Sharing study materials in health and medical research	3
The Six Steps of SDM: linking theory to practice, measurement and implementation	3
Towards the evolution of Evidence-Based Medicine	3
Rapid review methods series: Guidance on the use of supportive software	3
MetaImpact: a novel tool to enable evidence-based sample sizes for future trials	3
Re-evaluating the role of pilot trials in informing effect and sample size estimates for full-scale trials: a meta-epidemiological study	3